Pharmaceuticals & Biotech

Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.

  • 7 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Pharmaceuticals & Biotech

Discovery & Preclinical Targets, assays, animal models, and early safety/tox studies before human trials. Clinical Trials (Phases I–IV) Design, endpoints, enrollment, interim reads, and post‑market surveillance. Approvals, Safety & REMS FDA/EMA decisions, boxed warnings, pharmacovigilance, and label changes. Generics & Biosimilars Access, interchangeability, litigation, and pricing dynamics for follow‑ons. Vaccines & Immunization Platforms (mRNA, viral vector), boosters, schedules, and cold‑chain supply. Cell & Gene Therapies CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up. Manufacturing & Supply APIs, sterile fill‑finish, shortages, and quality systems across the supply chain.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals & Biotech

PlexusDx
plexusdx.com > blogs > learn > 10rx-reviews-pricing-pharmacies-customer-feedback-plexusdx

10Rx Reviews: Pricing, Pharmacies and Early Customer Feedback

1+ hour, 48+ min ago   (937+ words) Shop all 5 Weight Loss programs → Compare GLP-1 providers → Start Weight Loss intake → Shop all 5 Longevity programs → Start Longevity intake → GLP-1 & Peptide Pathways Food Sensitivity & Allergies Diet & Weight Loss Cognition and Brain Health Genetic Test Stress and Mental Health Genetic Test…...

Barrie 360
barrie360.com > weight-loss-drugs-grocery-pharma

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

4+ hour, 1+ min ago   (849+ words) While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of…...

PlexusDx
plexusdx.com > blogs > learn > big-easy-weight-loss-alternatives-plexusdx

Cheaper Alternatives to Big Easy Weight Loss: 2026 GLP-1 Pricing

1+ hour, 48+ min ago   (936+ words) Shop all 5 Weight Loss programs → Compare GLP-1 providers → Start Weight Loss intake → Shop all 5 Longevity programs → Start Longevity intake → GLP-1 & Peptide Pathways Food Sensitivity & Allergies Diet & Weight Loss Cognition and Brain Health Genetic Test Stress and Mental Health Genetic Test…...

The Republic News
therepublic.com > 09/13/2026 > lilly-fighting-black-market-for-its-next-obesity-drug

Lilly fighting black market for its next obesity drug

6+ hour, 56+ min ago   (1178+ words) Eli Lilly and Co.’s next weight-loss medication is not available. It has not been submitted for regulatory approval. It has not even completed late-stage clinical trials. But if you search “reta” or “retatrutide” on Instagram or TikTok, you will…...

Oncodaily - Oncology News
oncodaily.com > voices > servier-585580

Servier Partnering Day: Connecting Pharma, Biotech, and Academia for New Opportunities - OncoDaily

50+ min ago   (107+ words) Servier shared on LinkedIn: “We are excited to announce that the next edition of the Servier Partnering Day will take place in our Paris-Saclay R/D Institute on November 23rd! This unique event is designed to bring together pharma and biotech…...

BioPharma APAC
biopharmaapac.com > news > 86 > 8424 > exegenesis-bio-modalis-partner-to-advance-crispr-based-dmd-therapy-mdl-201.html

Exegenesis Bio, Modalis Partner to Advance CRISPR-Based DMD Therapy MDL-201

3+ hour, 8+ min ago   (68+ words) 14 September 2026 | Monday | News The financial impact of this research collaboration on Modalis' results for the current fiscal year is expected to be immaterial, and there is no revision to the earnings forecast at this time. Two Chairs, 11,000 Kilometres Apart: The…...

MedPage Today
medpagetoday.com > opinion > what-we-heard > 122972

Opinion | 'A Real-but-Vanilla Commercial Dispute': What We Heard This Week

1+ hour, 44+ min ago   (323+ words) — Quotable quotes heard by MedPage Today's reporters "The underlying case is a real-but-vanilla commercial dispute." -- Christopher Robertson, JD, PhD, of Boston University, discussing a medical software company's lawsuit against a former collaboratoropens in a new tab or window, who helped…...

WBAP
wbap.com > 09/13/2026 > fda-approves-isembyld-first-sma-treatment-to-target-muscle-loss

FDA Approves Isembyld, First SMA Treatment To Target Muscle Loss

2+ hour, 34+ min ago   (421+ words) A newly approved treatment for spinal muscular atrophy is moving toward U.S. availability, giving eligible children and adults an additional option to address muscle weakness. Scholar Rock announced September 11 that the Food and Drug Administration approved Isembyld, also known as apitegromab-mstn....

Google News
oncodaily.com > voices > cosimo-commisso-pancreatic-cancer-585561

Cosimo Commisso: Pancreatic Cancer Builds Immune Safe Zones to Evade Treatment

2+ hour, 17+ min ago   (197+ words) / Alessia Baccarini, Alexander Tepper, Bhavya Singh, Brian D. Brownsvg, cancer,, Alessia Baccarini, Alexander Tepper, Bhavya Singh, Brian D. Brownsvg, cancer, Chiara Falcomatà, Cosimo Commisso, Divya Chhamalwan, Gurkan Mollaoglu, Hunter T. Potak, Icahn School of Medicine at Mount Sinai, Matthew D. Park, Maxime…...

newsonair.gov.in
newsonair.gov.in > india-crosses-milestone-of-80-lakh-hpv-vaccinations

India crosses milestone of 80 lakh HPV vaccinations

3+ hour, 57+ min ago   (133+ words) newsonair.gov.in Play Audio Evening News News On AIR | September 11, 2026 12:18 PM India crosses milestone of 80 lakh HPV vaccinations India has crossed the significant milestone of 80 lakh Human Papillomavirus (HPV) vaccinations, marking another major step towards strengthening preventive healthcare and…...